A cancer diagnosis is scary enough in its self, but when the news comes in that it has also ‘metastasized’ or spread to other parts of the body, this is the most devastating news anyone can hear.
As we know, cancer cells proliferate uncontrollably with ‘no brakes‘ to halt their growth, therefore when cancerous tumors grow too big, it has to spread to other parts of the body and try to “attach itself” to a new spot which has less competition.
However, research has shown that there is something which has been found to keep ‘Galectin-3’ (the cancer cells’s anchor) in check and therefore inhibit cancer metastases and spread, with no evidence of toxicity or other serious side effects.
The discovery of Modified Citrus Pectin, also known as MCP, citrus pectin is not new as studies undertaken show, but it has obviously taken a good while to get this information out of the archives and into the public arena. Complementary practitioners should be well versed on it’s application and uses and if not please feel free to bring it to their attention.
MCP is composed of complex polysaccharides rich in galactoside residues, and is most abundant in citrus fruits, meaning the peel, seeds and pulp, which has been ‘modified‘ to make it’s active ingredients more bio-available and digestible.
Testing to determine ‘Galectin-3’ levels is mainly used as an indicator of metastases progression and spread and generally ordered by oncology practitioners. The main benefit of MCP is that it was found to block the ‘anchoring Galectin-3 attachment of cancer cells’ so as to inhibit cancer cells from metastasizing. The theory is that ‘if the floating cancer cells are unable to adhere to the organs, they will not be able to set up house and gain a hold on the blood supply, thereby limiting their potential to survive and grow‘.
Posted: 12/10/16 – Author: D. Blanch